UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Prediction of performance deterioration of rolling bearing based on JADE and PSO-SVM

Proceedings of the Institution of Mechanical Engineers. Part C, Journal of mechanical engineering science, 2021-05, Vol.235 (9), p.1684-1697

2021

Link zum Volltext

Verfügbarkeit prüfen

Research on Early Fault Diagnosis of Rolling Bearing Based on VMD

2018 6th International Conference on Mechanical, Automotive and Materials Engineering (CMAME), 2018, p.41-45

2018

Link zum Volltext
IEEE_Xplore

Cadonilimab, a tetravalent PD-1/CTLA-4 bispecific antibody with trans-binding and enhanced target binding avidity

mAbs, 2023, Vol.15 (1), p.2180794-2180794

2023

Link zum Volltext

Verfügbarkeit prüfen

Laser-assisted high-performance PtRu alloy for pH-universal hydrogen evolution

Energy & environmental science, 2022-01, Vol.15 (1), p.12-18

2022

Link zum Volltext

Verfügbarkeit prüfen

PHD-finger family genes in wheat ( Triticum aestivum L.): Evolutionary conservatism, functional diversification, and active expression in abiotic stress

Frontiers in plant science, 2022-12, Vol.13, p.1016831-1016831

2022

Link zum Volltext

Verfügbarkeit prüfen

The draft genome of watermelon (Citrullus lanatus) and resequencing of 20 diverse accessions

Nature genetics, 2013-01, Vol.45 (1), p.51-58

2013

Link zum Volltext

Verfügbarkeit prüfen

Rv3737 is required for Mycobacterium tuberculosis growth in vitro and in vivo and correlates with bacterial load and disease severity in human tuberculosis

BMC infectious diseases, 2022-03, Vol.22 (1), p.256-256, Article 256

2022

Link zum Volltext

Verfügbarkeit prüfen

A facile method prepared nitrogen and boron doped carbon nano-tube based catalysts for oxygen reduction

International journal of hydrogen energy, 2017-02, Vol.42 (7), p.4123-4132

2017

Link zum Volltext

Verfügbarkeit prüfen

Penpulimab, an Fc-Engineered IgG1 Anti-PD-1 Antibody, With Improved Efficacy and Low Incidence of Immune-Related Adverse Events

Frontiers in immunology, 2022-06, Vol.13, p.924542-924542

2022

Link zum Volltext

Verfügbarkeit prüfen

Self-Optimized Ligand Effect of Single-Atom Modifier in Ternary Pt-Based Alloy for Efficient Hydrogen Oxidation

Nano letters, 2023-05, Vol.23 (9), p.3826-3834

2023

Link zum Volltext

Verfügbarkeit prüfen

Ligufalimab, a novel anti-CD47 antibody with no hemagglutination demonstrates both monotherapy and combo antitumor activity

Journal for immunotherapy of cancer, 2022-11, Vol.10 (11), p.e005517

2022

Link zum Volltext

Verfügbarkeit prüfen

Controls of organic and inorganic compositions on pore structure of lacustrine shales of Chang 7 member from Triassic Yanchang Formation in the Ordos Basin, China

Marine and petroleum geology, 2019-02, Vol.100, p.270-284

2019

Link zum Volltext

Verfügbarkeit prüfen

1194 Mechanism of action of ivonescimab (AK112/SMT112): a first-in-class tetravalent Fc-silent bispecific antibody with dual blockade of PD-1 and VEGF that promotes cooperative biological effects

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1316-A1317

2023

Link zum Volltext

Verfügbarkeit prüfen

266 AK117, a CD47 blocking antibody with robust macrophage activation without red blood cell hemagglutination

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A288-A289

2021

Link zum Volltext

Verfügbarkeit prüfen

289 Cadonilimab, an anti-PD1/CTLA4 bi-specific antibody with Fc effector null backbone

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A313-A314

2021

Link zum Volltext

Verfügbarkeit prüfen

Preclinical characterization of WB737, a potent and selective STAT3 inhibitor, in natural killer/T‐cell lymphoma

MedComm (2020), 2023-08, Vol.4 (4), p.e284-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3827: Bispecific antibodies with an anti-PD-1 backbone for cancer therapy generate enhanced immune activity

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3827-3827

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5520: AK129, an anti-PD1/LAG-3 bi-specific antibody for cancer therapy

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.5520-5520

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5526: AK131, an anti-PD1/CD73 bispecific antibody for cancer immune therapy

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.5526-5526

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5524: AK127, a novel monoclonal antibody (mAb) targeting T cell immunoreceptor (TIGIT)

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.5524-5524

2022

Link zum Volltext

Verfügbarkeit prüfen

476 AK119, a humanized anti-CD73 monoclonal antibody, as Immunotherapy for COVID-19

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A508-A508

2020

Link zum Volltext

Verfügbarkeit prüfen

750 AK119, a CD73 targeting antibody with dual mechanism of action

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A783-A784

2021

Link zum Volltext

Verfügbarkeit prüfen

702 Dual blockade of the PD-1 checkpoint pathway and the adenosinergic negative feedback signaling pathway with a PD-1/CD73 bispecific antibody for cancer immune therapy

Journal for immunotherapy of cancer, 2020, Vol.8 (Suppl 3), p.A422-A422

2020

Link zum Volltext

Verfügbarkeit prüfen

184 Two types of anti-TIGIT antibodies with distinct binding epitope and functional activities

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A109-A109

2020

Link zum Volltext

Verfügbarkeit prüfen

Cadonilimab, a tetravalent PD-1/CTLA-4 bispecific antibody with trans-binding and enhanced target binding avidity

mAbs, 2023, Vol.15 (1)

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(24)

Publikationsform

Sprache

Englisch
(25)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Life Sciences & Biomedicine
(8)
Antibodies
(6)
Technology
(5)
Immunotherapy
(4)
Physical Sciences
(4)
Cancer
(3)
Chemistry
(3)
Engineering
(3)
Regular And Young Investigator Award Abstracts
(3)
Adenosine
(2)
Anemia
(2)
Antibodies, Bispecific
(2)
Antigens
(2)
Chemistry, Multidisciplinary
(2)
Chemistry, Physical
(2)
Cytotoxicity
(2)
Drug Retention
(2)
Energy & Fuels
(2)
Engineering, Mechanical
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prediction of performance deterioration of rolling bearing based on JADE and PSO-SVM

Research on Early Fault Diagnosis of Rolling Bearing Based on VMD

Cadonilimab, a tetravalent PD-1/CTLA-4 bispecific antibody with trans-binding and enhanced target binding avidity

Laser-assisted high-performance PtRu alloy for pH-universal hydrogen evolution

PHD-finger family genes in wheat ( Triticum aestivum L.): Evolutionary conservatism, functional diversification, and active expression in abiotic stress

The draft genome of watermelon (Citrullus lanatus) and resequencing of 20 diverse accessions

Rv3737 is required for Mycobacterium tuberculosis growth in vitro and in vivo and correlates with bacterial load and disease severity in human tuberculosis

A facile method prepared nitrogen and boron doped carbon nano-tube based catalysts for oxygen reduction

Penpulimab, an Fc-Engineered IgG1 Anti-PD-1 Antibody, With Improved Efficacy and Low Incidence of Immune-Related Adverse Events

Self-Optimized Ligand Effect of Single-Atom Modifier in Ternary Pt-Based Alloy for Efficient Hydrogen Oxidation

Ligufalimab, a novel anti-CD47 antibody with no hemagglutination demonstrates both monotherapy and combo antitumor activity

Controls of organic and inorganic compositions on pore structure of lacustrine shales of Chang 7 member from Triassic Yanchang Formation in the Ordos Basin, China

1194 Mechanism of action of ivonescimab (AK112/SMT112): a first-in-class tetravalent Fc-silent bispecific antibody with dual blockade of PD-1 and VEGF that promotes cooperative biological effects

266 AK117, a CD47 blocking antibody with robust macrophage activation without red blood cell hemagglutination

289 Cadonilimab, an anti-PD1/CTLA4 bi-specific antibody with Fc effector null backbone

Preclinical characterization of WB737, a potent and selective STAT3 inhibitor, in natural killer/T‐cell lymphoma

Abstract 3827: Bispecific antibodies with an anti-PD-1 backbone for cancer therapy generate enhanced immune activity

Abstract 5520: AK129, an anti-PD1/LAG-3 bi-specific antibody for cancer therapy

Abstract 5526: AK131, an anti-PD1/CD73 bispecific antibody for cancer immune therapy

Abstract 5524: AK127, a novel monoclonal antibody (mAb) targeting T cell immunoreceptor (TIGIT)

476 AK119, a humanized anti-CD73 monoclonal antibody, as Immunotherapy for COVID-19

750 AK119, a CD73 targeting antibody with dual mechanism of action

702 Dual blockade of the PD-1 checkpoint pathway and the adenosinergic negative feedback signaling pathway with a PD-1/CD73 bispecific antibody for cancer immune therapy

184 Two types of anti-TIGIT antibodies with distinct binding epitope and functional activities

Cadonilimab, a tetravalent PD-1/CTLA-4 bispecific antibody with trans-binding and enhanced target binding avidity

Suchergebnisse filtern